Skip to main content
SpringerLink
Log in

Gastrointestinal Symptoms: Nausea and Vomiting

  • Living reference work entry
  • First Online:
Textbook of Palliative Care

  • 548 Accesses

Abstract

This chapter examines nausea and vomiting affecting patients who suffer from serious illness. A deeper understanding of these physiologic processes allows for a better assessment and management. There are several different pharmacological and non-pharmacological options to improve palliation, including complementary and alternative medicines. Ultimately, there should be an individualized approach that considers the trajectory of illness, co-morbidities, and most importantly is patient centered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Aapro M. 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment. Oncology. 2005;69(2):97–109.

    Article  PubMed  CAS  Google Scholar 

  • American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.

    Article  Google Scholar 

  • Amesbury B, Alloway L, Hickmore E, Dewhurst G. High-dose levomepromazine (methotrimeprazine) to control nausea in carcinoid syndrome. J Palliat Care. 2004;20(2):117–8.

    PubMed  Google Scholar 

  • Anchin JM, Subramaniam S, Linthicum DS. Binding of the neuroleptic drug haloperidol to a monoclonal antibody: refinement of the binding site molecular model using canonical structures. J Mol Recognit. 1991;4(1):7–15.

    Article  PubMed  CAS  Google Scholar 

  • Andrews PL, Sanger GJ. Nausea and the quest for the perfect anti-emetic. Eur J Pharmacol. 2014;722:108–21.

    Article  PubMed  CAS  Google Scholar 

  • Ang SK, Shoemaker LK, Davis MP. Nausea and vomiting in advanced cancer. Am J Hosp Palliat Care. 2010;27(3):219–25.

    Article  PubMed  Google Scholar 

  • Atkinson SR. Olanzapine for intractable nausea and vomiting in palliative care patients not receiving chemotherapy. J Palliat Med. 2014;17(5):503–4.

    Article  PubMed  Google Scholar 

  • Babic T, Browning KN. The role of vagal neurocircuits in the regulation of nausea and vomiting. Eur J Pharmacol. 2014;722:38–47.

    Article  PubMed  CAS  Google Scholar 

  • Barkin JS, Goldberg RI, Sfakianakis GN, Levi J. Pancreatic carcinoma is associated with delayed gastric emptying. Dig Dis Sci. 1986;31(3):265–7.

    Article  PubMed  CAS  Google Scholar 

  • Barr RG, Rowe BG, Camargo CA Jr. Methylxanthines for exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomised trials. BMJ. 2003;327(7416):643–49.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bentley A, Boyd K. Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med. 2001;15(3):247–53.

    Article  PubMed  CAS  Google Scholar 

  • Benze G, Alt-Epping B, Geyer A, Nauck F. Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients: a review. Schmerz. 2012;26(5):500–14.

    Article  PubMed  CAS  Google Scholar 

  • Bliss JM, Robertson B, Selby PJ. The impact of nausea and vomiting upon quality of life measures. Br J Cancer Suppl. 1992;19:S14–22; discussion S3.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Brooksbank MA, Game PA, Ashby MA. Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med. 2002;16(6):520–6.

    Article  PubMed  CAS  Google Scholar 

  • Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6–9.

    PubMed  CAS  Google Scholar 

  • Bruera E, Seifert L, Watanabe S, Babul N, Darke A, Harsanyi Z, et al. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manag. 1996;11(3):147–53.

    Article  CAS  Google Scholar 

  • Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manag. 2000;19(6):427–35.

    Article  CAS  Google Scholar 

  • Bruera E, Moyano JR, Sala R, Rico MA, Bosnjak S, Bertolino M, et al. Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manag. 2004;28(4):381–8.

    Article  CAS  Google Scholar 

  • Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. American College of G. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–37; quiz 8.

    Article  PubMed  CAS  Google Scholar 

  • Campora E, Merlini L, Pace M, Bruzzone M, Luzzani M, Gottlieb A, et al. The incidence of narcotic-induced emesis. J Pain Symptom Manag. 1991;6(7):428–30.

    Article  CAS  Google Scholar 

  • Chang VT, Hwang SS, Kasimis B, Thaler HT. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Investig. 2004;22(4):526–36.

    Article  Google Scholar 

  • Chanthawong S, Subongkot S, Sookprasert A. Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting. J Med Assoc Thailand. 2014;97(3):349–55.

    Google Scholar 

  • Cheung WY, Le LW, Zimmermann C. Symptom clusters in patients with advanced cancers. Support care cancer. 2009;17(9):1223–30.

    Article  PubMed  Google Scholar 

  • Chiu L, Chow R, Popovic M, Navari RM, Shumway NM, Chiu N, et al. Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis. Support Care Cancer. 2016;24(5):2381–92.

    Article  PubMed  Google Scholar 

  • Clissold SP, Heel RC. Transdermal hyoscine (scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985;29(3):189–207.

    Article  PubMed  CAS  Google Scholar 

  • Collis E, Mather H. Nausea and vomiting in palliative care. BMJ. 2015;351:h6249.

    Article  PubMed  CAS  Google Scholar 

  • Coluzzi F, Rocco A, Mandatori I, Mattia C. Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation. Curr Pharm Des. 2012;18(37):6043–52.

    Article  PubMed  CAS  Google Scholar 

  • Cousins SE, Tempest E, Feuer DJ. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2016;1:CD002764.

    Google Scholar 

  • Cox L, Darvill E, Dorman S. Levomepromazine for nausea and vomiting in palliative care. Cochrane Database Syst Rev. 2015;11:CD009420.

    Google Scholar 

  • Currow DC, Abernethy AP. Five years’ time and the next five things for the list of choosing wisely. J Palliat Med. 2013;16(6):594–5.

    Article  PubMed  Google Scholar 

  • Dahl S, Refsum H. Effects of levomepromazine, chlorpromazine and their sulfoxides on isolated rat atria. Eur J Pharmacol. 1976;37(2):241–8.

    Article  PubMed  CAS  Google Scholar 

  • Davis MP, Hallerberg G. Palliative Medicine Study Group of the Multinational Association of Supportive Care in C. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manag. 2010;39(4):756–67.

    Article  Google Scholar 

  • Davis MP, Walsh D. Treatment of nausea and vomiting in advanced cancer. Supportive Care Cancer. 2000;8(6):444–52.

    Article  CAS  Google Scholar 

  • DeEulis TG, Yennurajalingam S. Venting gastrostomy at home for symptomatic management of bowel obstruction in advanced/recurrent ovarian malignancy: a case series. J Palliat Med. 2015;18(8):722–8.

    Article  PubMed  Google Scholar 

  • Dietz I, Schmitz A, Lampey I, Schulz C. Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review. BMC Palliat Care. 2013;12:2.

    Article  PubMed  PubMed Central  Google Scholar 

  • Diver E, O'Connor O, Garrett L, Boruta D, Goodman A, Del Carmen M, et al. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecol Oncol. 2013;129(2):332–5.

    Article  PubMed  Google Scholar 

  • Dolan EA. Malignant bowel obstruction: a review of current treatment strategies. Am J Hosp Palliat Care. 2011;28(8):576–82.

    Article  PubMed  Google Scholar 

  • dos Santos LV, Souza FH, Brunetto AT, Sasse AD, da Silveira Nogueira Lima JP. Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review. J Natl Cancer Inst. 2012;104(17):1280–92.

    Article  PubMed  CAS  Google Scholar 

  • Dossett ML, Davis RB, Lembo AJ, Yeh GY. Complementary and alternative medicine use by US adults with gastrointestinal conditions: results from the 2012 National Health Interview Survey. Am J Gastroenterol. 2014;109(11):1705–11.

    Article  PubMed  PubMed Central  Google Scholar 

  • Dunn LT. Raised intracranial pressure. J Neurol Neurosurg Psychiatry. 2002;73(Suppl 1):i23–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Eisenchlas JH, Garrigue N, Junin M, De Simone GG. Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study. Palliat Med. 2005;19(1):71–5.

    Article  PubMed  Google Scholar 

  • Ejskjaer NT, Bradley JL, Buxton-Thomas MS, Edmonds ME, Howard ER, Purewal T, et al. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet med. 1999;16(6):488–95.

    Article  PubMed  CAS  Google Scholar 

  • Entrena JM, Cobos EJ, Nieto FR, Cendan CM, Baeyens JM, Del Pozo E. Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors. Psychopharmacology. 2009;205(1):21–33.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Farmer AD, Ban VF, Coen SJ, Sanger GJ, Barker GJ, Gresty MA, et al. Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans. J Physiol. 2015;593(5):1183–96.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Fletcher DS, Coyne PJ, Dodson PW, Parker GG, Wan W, Smith TJ. A randomized trial of the effectiveness of topical “ABH Gel” (Ativan((R)), Benadryl((R)), Haldol((R))) vs. placebo in cancer patients with nausea. J Pain Symptom Manag. 2014;48(5):797–803.

    Article  Google Scholar 

  • Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang P, et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013;31(7):952–60.

    Article  PubMed  PubMed Central  Google Scholar 

  • Glare P, Pereira G, Kristjanson LJ, Stockler M, Tattersall M. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer. 2004;12(6):432–40.

    Article  PubMed  Google Scholar 

  • Glare P, Miller J, Nikolova T, Tickoo R. Treating nausea and vomiting in palliative care: a review. Clin Interv Aging. 2011;6:243–59.

    Article  PubMed  PubMed Central  Google Scholar 

  • Goodin S, Cunningham R. 5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile. Oncologist. 2002;7(5):424–36.

    Article  PubMed  CAS  Google Scholar 

  • Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol. 1999;17(9):2971–94.

    Article  PubMed  CAS  Google Scholar 

  • Greaves J, Glare P, Kristjanson LJ, Stockler M, Tattersall MH. Undertreatment of nausea and other symptoms in hospitalized cancer patients. Support care cancer. 2009;17(4):461–4.

    Article  PubMed  Google Scholar 

  • Grimes JD, Hassan MN, Preston DN. Adverse neurologic effects of metoclopramide. Can Med Assoc J. 1982;126(1):23–5.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Gupta D, Mazumdar A, Stellini M. A physiological perspective for utility or futility of alcohol-based hand rub gel against nausea-vomiting: is it P-6 acupoint or transnasal aroma? Am J Hosp Palliat Care. 2014;31(6):608–10.

    Article  PubMed  Google Scholar 

  • Hafermann MJ, Namdar R, Seibold GE, Page RL 2nd. Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study. Drug Healthcare Patient Safety. 2011;3:53–8.

    CAS  Google Scholar 

  • Hardy J, Daly S, McQuade B, Albertsson M, Chimontsi-Kypriou V, Stathopoulos P, et al. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Support Care Cancer. 2002;10(3):231–6.

    Article  PubMed  CAS  Google Scholar 

  • Hardy JR, O'Shea A, White C, Gilshenan K, Welch L, Douglas C. The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. J Pain Symptom Manag. 2010;40(1):111–6.

    Article  CAS  Google Scholar 

  • Hasler WL. Pathology of emesis: its autonomic basis. Handb Clin Neurol. 2013;117:337–52.

    Article  PubMed  Google Scholar 

  • Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, et al. The association between intravenous haloperidol and prolonged QT interval. J Clin Psychopharmacol. 2001;21(3):257–61.

    Article  PubMed  CAS  Google Scholar 

  • Helmeste DM, Seeman P. [3H]haloperidol binding to more than one site in rat brain striatum. Biochem Pharmacol. 1983;32(4):741–4.

    Article  PubMed  CAS  Google Scholar 

  • Hisanaga T, Shinjo T, Morita T, Nakajima N, Ikenaga M, Tanimizu M, et al. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction. Jpn J Clin Oncol. 2010;40(8):739–45.

    Article  PubMed  Google Scholar 

  • Ho CM, Ho ST, Wang JJ, Tsai SK, Chai CY. Dexamethasone has a central antiemetic mechanism in decerebrated cats. Anesth Analg. 2004;99(3):734–9; table of contents.

    Article  PubMed  CAS  Google Scholar 

  • Horn CC. Why is the neurobiology of nausea and vomiting so important? Appetite. 2008;50(2–3):430–4.

    Article  PubMed  Google Scholar 

  • Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111(Suppl 8A):106S–12S.

    Article  PubMed  Google Scholar 

  • Hussain ZH, Whitehead DA, Lacy BE. Fecal impaction. Curr Gastroenterol Rep. 2014;16(9):404.

    Article  PubMed  Google Scholar 

  • Issaka RB, Shapiro DM, Parikh ND, Mulcahy MF, Komanduri S, Martin JA, et al. Palliative venting percutaneous endoscopic gastrostomy tube is safe and effective in patients with malignant obstruction. Surg Endosc. 2014;28(5):1668–73.

    Article  PubMed  Google Scholar 

  • Jordan K, Sippel C, Schmoll HJ. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. Oncologist. 2007;12(9):1143–50.

    Article  PubMed  CAS  Google Scholar 

  • Kaneishi K, Nishimura K, Sakurai N, Imai K, Matsuo N, Takahashi N, et al. Use of olanzapine for the relief of nausea and vomiting in patients with advanced cancer: a multicenter survey in Japan. Support Care Cancer. 2016;24(6):2393–5.

    Article  PubMed  Google Scholar 

  • Kennett A, Hardy J, Shah S, A'Hern R. An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2005;13(9):715–21.

    Article  PubMed  CAS  Google Scholar 

  • Kirkova J, Rybicki L, Walsh D, Aktas A. Symptom prevalence in advanced cancer: age, gender, and performance status interactions. Am J Hosp Palliat Care. 2012;29(2):139–45.

    Article  PubMed  Google Scholar 

  • Laval G, Marcelin-Benazech B, Guirimand F, Chauvenet L, Copel L, Durand A, et al. Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manag. 2014;48(1):75–91.

    Article  Google Scholar 

  • Lee A, Kuo B. Metoclopramide in the treatment of diabetic gastroparesis. Expert Rev endocrinol Metabol. 2010;5(5):653–62.

    Article  CAS  Google Scholar 

  • Lee A, Chan SK, Fan LT. Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2015;11:CD003281.

    PubMed Central  Google Scholar 

  • Machado Rocha FC, Stefano SC, De Cassia Haiek R, Rosa Oliveira LM, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care. 2008;17(5):431–43.

    Article  CAS  Google Scholar 

  • MacKintosh D. Olanzapine in the management of difficult to control nausea and vomiting in a palliative care population: a case series. J Palliat Med. 2016;19(1):87–90.

    Article  PubMed  Google Scholar 

  • Marx W, Kiss N, Isenring L. Is ginger beneficial for nausea and vomiting? An update of the literature. Curr Opin Support Palliat Care. 2015;9(2):189–95.

    Article  PubMed  Google Scholar 

  • Mayer EA, Tillisch K, Ellingson BM. Dyspepsia: structural changes in functional gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2013;10(4):200–2.

    Article  PubMed  Google Scholar 

  • Meiri E, Jhangiani H, Vredenburgh JJ, Barbato LM, Carter FJ, Yang HM, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin. 2007;23(3):533–43.

    Article  PubMed  CAS  Google Scholar 

  • Molassiotis A, Russell W, Hughes J, Breckons M, Lloyd-Williams M, Richardson J, et al. The effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: a randomized controlled trial. J Pain Symptom Manag. 2014;47(1):12–25.

    Article  Google Scholar 

  • Moradian S, Walshe C, Shahidsales S, Ghavam Nasiri MR, Pilling M, Molassiotis A. Nevasic audio program for the prevention of chemotherapy induced nausea and vomiting: a feasibility study using a randomized controlled trial design. Eur J Oncol Nurs. 2015;19(3):282–91.

    Article  PubMed  Google Scholar 

  • Mystakidou K, Befon S, Liossi C, Vlachos L. Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting of patients with advanced cancer. J Pain Symptom Manag. 1998;15(3):176–84.

    Article  CAS  Google Scholar 

  • Napadow V, Sheehan JD, Kim J, Lacount LT, Park K, Kaptchuk TJ, et al. The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex. 2013;23(4):806–13.

    Article  PubMed  Google Scholar 

  • Navari RM, Brenner MC. Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. Support Care Cancer. 2010;18(8):951–6.

    Article  PubMed  Google Scholar 

  • Navari RM, Einhorn LH, Loehrer PJ Sr, Passik SD, Vinson J, McClean J, et al. A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study. Support Care Cancer. 2007;15(11):1285–91.

    Article  PubMed  Google Scholar 

  • Navari RM, Brenner MC, Wilson MN. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat. 2008;112(1):197–201.

    Article  PubMed  CAS  Google Scholar 

  • O'Grady G, Egbuji JU, Du P, Cheng LK, Pullan AJ, Windsor JA. High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg. 2009;33(8):1693–701.

    Article  PubMed  PubMed Central  Google Scholar 

  • O'Grady G, Wang TH, Du P, Angeli T, Lammers WJ, Cheng LK. Recent progress in gastric arrhythmia: pathophysiology, clinical significance and future horizons. Clin Exp Pharmacol Physiol. 2014;41(10):854–62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pan CX, Morrison RS, Ness J, Fugh-Berman A, Leipzig RM. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manag. 2000;20(5):374–87.

    Article  CAS  Google Scholar 

  • Parker LA, Rock EM, Limebeer CL. Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol. 2011;163(7):1411–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Passik SD, Lundberg J, Kirsh KL, Theobald D, Donaghy K, Holtsclaw E, et al. A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manag. 2002;23(6):526–32.

    Article  CAS  Google Scholar 

  • Passik SD, Navari RM, Jung SH, Nagy C, Vinson J, Kirsh KL, et al. A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study. Cancer Investig. 2004;22(3):383–8.

    Article  CAS  Google Scholar 

  • Patt RB. Pharmacotherapy for cancer pain: an anaesthesiologist’s viewpoint. Ann Acad Med Singap. 1994;23(4):598–609.

    PubMed  CAS  Google Scholar 

  • Pertwee RG. Pharmacology of cannabinoid receptor ligands. Curr Med Chem. 1999;6(8):635–64.

    PubMed  CAS  Google Scholar 

  • Pyykko I, Padoan S, Schalen L, Lyttkens L, Magnusson M, Henriksson NG. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus. Aviat Space Environ Med. 1985;56(8):777–82.

    PubMed  CAS  Google Scholar 

  • Richards CA, Andrews PL. Emesis as a model system for the study of functional bowel disease. J Pediatr Gastroenterol Nutr. 2007;45(Suppl 2):S120–6.

    Article  PubMed  Google Scholar 

  • Richards DM, Tanikella R, Arora G, Guha S, Dekovich AA. Percutaneous endoscopic gastrostomy in cancer patients: predictors of 30-day complications, 30-day mortality, and overall mortality. Dig Dis Sci. 2013;58(3):768–76.

    Article  PubMed  Google Scholar 

  • Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E, et al. MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol. 2016;27(Suppl 5):v119–v33.

    Article  PubMed  CAS  Google Scholar 

  • Rojas C, Slusher BS. Pharmacological mechanisms of 5-HT(3) and tachykinin NK(1) receptor antagonism to prevent chemotherapy-induced nausea and vomiting. Eur J Pharmacol. 2012;684(1–3):1–7.

    Article  PubMed  CAS  Google Scholar 

  • Romero L, Merlos M, Vela JM. Antinociception by Sigma-1 receptor antagonists: central and peripheral effects. Adv Pharmacol. 2016;75:179–215.

    Article  PubMed  Google Scholar 

  • Salpeter SR, Buckley JS, Bruera E. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med. 2013;16(6):616–22.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sclocco R, Citi L, Garcia RG, Cerutti S, Bianchi AM, Kuo B, et al. Combining sudomotor nerve impulse estimation with fMRI to investigate the central sympathetic response to nausea. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference 2015;2015:4683–4686.

    Google Scholar 

  • Shaw C, Bassett RL, Fox PS, Schmeler KM, Overman MJ, Wallace MJ, et al. Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites. Ann Surg Oncol. 2013;20(2):497–505.

    Article  PubMed  Google Scholar 

  • Sherman MA, Bolger MB. Haloperidol binding to monoclonal antibodies. Predictions of three-dimensional combining site structure via computer modeling. J Biol Chem. 1988;263(9):4064–74.

    PubMed  CAS  Google Scholar 

  • Singh P, Yoon SS, Kuo B. Nausea: a review of pathophysiology and therapeutics. Ther Adv Gastroenterol. 2016;9(1):98–112.

    Article  CAS  Google Scholar 

  • Slatkin NE. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. J Support Oncol. 2007;5(Suppl 3):1–9.

    PubMed  CAS  Google Scholar 

  • Smith HS, Laufer A. Opioid induced nausea and vomiting. Eur J Pharmacol. 2014;722:67–78.

    Article  PubMed  CAS  Google Scholar 

  • Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev. 2015;11:CD009464.

    Google Scholar 

  • Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manag. 2006;31(1):58–69.

    Article  Google Scholar 

  • Stanghellini V, Talley NJ, Chan F, Hasler WL, Malagelada J, Suzuki H, et al. Rome IV – Gastroduodenal disorders. Gastroenterology. 2016;150(6):1380–1392.

    Article  PubMed  Google Scholar 

  • Steinhoff MS, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett NW. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol Rev. 2014;94(1):265–301.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Stephenson J, Davies A. An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2006;14(4):348–53.

    Article  PubMed  Google Scholar 

  • Stern RM. The psychophysiology of nausea. Acta Biol Hung. 2002;53(4):589–99.

    Article  PubMed  CAS  Google Scholar 

  • Tageja N, Groninger H. Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines. Postgrad Med J. 2016;92(1083):34–40.

    Article  PubMed  CAS  Google Scholar 

  • Teriaky A, Gregor J, Chande N. Percutaneous endoscopic gastrostomy tube placement for end-stage palliation of malignant gastrointestinal obstructions. Saudi J Gastroenterol. 2012;18(2):95–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Thosani S, Hu MI. Denosumab: a new agent in the management of hypercalcemia of malignancy. Future Oncol. 2015;11(21):2865–71.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs. 2007;67(9):1343–57.

    Article  PubMed  CAS  Google Scholar 

  • Vanaki Z, Matourypour P, Gholami R, Zare Z, Mehrzad V, Dehghan M. Therapeutic touch for nausea in breast cancer patients receiving chemotherapy: composing a treatment. Complement Ther Clin Pract. 2016;22:64–8.

    Article  PubMed  Google Scholar 

  • Walsh D, Davis M, Ripamonti C, Bruera E, Davies A, Molassiotis A. 2016 Updated MASCC/ESMO consensus recommendations: management of nausea and vomiting in advanced cancer. Support Care Cancer. 2017;25(1):333–40.

    Article  PubMed  Google Scholar 

  • Watari H, Hosaka M, Wakui Y, Nomura E, Hareyama H, Tanuma F, et al. A prospective study on the efficacy of octreotide in the management of malignant bowel obstruction in gynecologic cancer. Int J Gynecol Cancer. 2012;22(4):692–6.

    Article  PubMed  Google Scholar 

  • Watkins PJ, Buxton-Thomas MS, Howard ER. Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med. 2003;20(1):58–63.

    Article  PubMed  CAS  Google Scholar 

  • Yuan CS, Foss JF, O'Connor M, Osinski J, Roizen MF, Moss J. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study. Pain. 1999;83(3):631–5.

    Article  PubMed  CAS  Google Scholar 

  • Zhao XD, Cai BB, Cao RS, Shi RH. Palliative treatment for incurable malignant colorectal obstructions: a meta-analysis. World J Gastroenterol. 2013;19(33):5565–74.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Palliative Medicine, Geisinger Health System, Danville, PA, USA

    Bertrand Behm & Carlos Fernandez

  2. Department of Palliative Care, Geisinger Medical Center, Danville, PA, USA

    Mellar P. Davis

Authors
  1. Bertrand Behm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mellar P. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bertrand Behm .

Editor information

Editors and Affiliations

  1. HammondCare Learning and Research Centre, Greenwich Hospital, Greenwich, New South Wales, Australia

    Roderick Duncan MacLeod

  2. Vrije Universiteit Brussel, VUB-UGent End-of-Life Care Research Grou Vrije Universiteit Brussel, Brussels, Belgium

    Lieve Van den Block

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Behm, B., Fernandez, C., Davis, M.P. (2018). Gastrointestinal Symptoms: Nausea and Vomiting. In: MacLeod, R., Van den Block, L. (eds) Textbook of Palliative Care. Springer, Cham. https://doi.org/10.1007/978-3-319-31738-0_15-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31738-0_15-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31738-0

  • Online ISBN: 978-3-319-31738-0

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Search

Navigation